217 results on '"Derosa, Lisa"'
Search Results
2. Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance
3. Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
4. Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
5. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
6. Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
7. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
8. Melanoma and microbiota: Current understanding and future directions
9. Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
10. Benzodiazepines compromise the outcome of cancer immunotherapy.
11. Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors.
12. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
13. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
14. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
15. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease
16. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
17. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
18. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae
19. Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
20. State of the art and the future of microbiome-based biomarkers:a multidisciplinary Delphi consensus
21. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
22. New pathways in immune stimulation: targeting OX40
23. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
24. A probiotic supplement boosts response to cancer immunotherapy
25. Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?
26. The impact of the intestinal microbiota in therapeutic responses against cancer
27. Anticorps monoclonaux en oncologie : déclencher une réponse immunitaire en plus de la réduction tumorale spécifique.
28. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
29. Immunodynamics of explanted human tumors for immuno‐oncology
30. Defective Immunity Against SARS-CoV-2 Omicron Variants Despite Full Vaccination in Hematologic Malignancies
31. RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
32. Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
33. Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma
34. Cancer induces a stress ileopathy depending on B-adrenergic receptors and promoting dysbiosis that contribute to carcinogenesis
35. Cancer Induces a Stress Ileopathy Depending on beta-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
36. Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters
37. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in advanced non-small cell lung cancer patients
38. Modulation of cancer immunotherapy by dietary fibers and over-the-counter probiotics
39. Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer
40. Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients
41. Cancer induces a stress ileopathy depending on B-adrenergic receptors and promoting dysbiosis that contribute to carcinogenesis
42. Immunodynamics of explanted human tumors for immuno‐oncology
43. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
44. Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites
45. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
46. Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma
47. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study
48. Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses
49. Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors
50. Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.